Literature DB >> 33320080

COVID-19 and Fatal Sepsis Caused by Hypervirulent Klebsiella pneumoniae, Japan, 2020.

Tomohiro Hosoda, Sohei Harada, Koh Okamoto, Sumire Ishino, Makoto Kaneko, Masahiro Suzuki, Ryota Ito, Miyuki Mizoguchi.   

Abstract

A patient in Japan with coronavirus disease and hypervirulent Klebsiella pneumoniae K2 sequence type 86 infection died of respiratory failure. Bacterial and fungal co-infections caused by region-endemic pathogens, including hypervirulent K. pneumoniae in eastern Asia, should be included in the differential diagnosis of coronavirus disease patients with acutely deteriorating condition.

Entities:  

Keywords:  2019 novel coronavirus disease; COVID-19; Japan; SARS-CoV-2; bacteria; co-infection; coronavirus disease; hypervirulent Klebsiella pneumoniae; respiratory infections; sepsis; severe acute respiratory syndrome coronavirus 2; string test; viruses; zoonoses

Mesh：

Year:  2020        PMID： 33320080      PMCID： PMC7853555          DOI： 10.3201/eid2702.204662

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  15 in total

1.  Multiplex PCR for detection of seven virulence factors and K1/K2 capsular serotypes of Klebsiella pneumoniae.

Authors:  Fabrice Compain; Ana Babosan; Sylvain Brisse; Nathalie Genel; Jennifer Audo; Florent Ailloud; Najiby Kassis-Chikhani; Guillaume Arlet; Dominique Decré
Journal:  J Clin Microbiol       Date:  2014-10-01       Impact factor: 5.948

2.  Clinical and Molecular Characteristics of Klebsiella pneumoniae Isolates Causing Bloodstream Infections in Japan: Occurrence of Hypervirulent Infections in Health Care.

Authors:  Sohei Harada; Kotaro Aoki; Shungo Yamamoto; Yoshikazu Ishii; Noritaka Sekiya; Hanako Kurai; Keiichi Furukawa; Asako Doi; Kentaro Tochitani; Kenji Kubo; Yukihiro Yamaguchi; Masashi Narita; Shinya Kamiyama; Jun Suzuki; Takahiko Fukuchi; Yoshiaki Gu; Keiji Okinaka; Soichi Shiiki; Kayoko Hayakawa; Natsuo Tachikawa; Kei Kasahara; Tadahiro Nakamura; Kyoko Yokota; Masanari Komatsu; Misaki Takamiya; Kazuhiro Tateda; Yohei Doi
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

Review 3.  Klebsiella pneumoniae liver abscess: a new invasive syndrome.

Authors:  L Kristopher Siu; Kuo-Ming Yeh; Jung-Chung Lin; Chang-Phone Fung; Feng-Yee Chang
Journal:  Lancet Infect Dis       Date:  2012-11       Impact factor: 25.071

4.  Mapping the Evolution of Hypervirulent Klebsiella pneumoniae.

Authors:  Carsten Struve; Chandler C Roe; Marc Stegger; Steen G Stahlhut; Dennis S Hansen; David M Engelthaler; Paal S Andersen; Elizabeth M Driebe; Paul Keim; Karen A Krogfelt
Journal:  MBio       Date:  2015-07-21       Impact factor: 7.867

5.  Gastrointestinal Carriage Is a Major Reservoir of Klebsiella pneumoniae Infection in Intensive Care Patients.

Authors:  Claire L Gorrie; Mirjana Mirceta; Ryan R Wick; David J Edwards; Nicholas R Thomson; Richard A Strugnell; Nigel F Pratt; Jill S Garlick; Kerri M Watson; David V Pilcher; Steve A McGloughlin; Denis W Spelman; Adam W J Jenney; Kathryn E Holt
Journal:  Clin Infect Dis       Date:  2017-07-15       Impact factor: 9.079

6.  Co-infection with respiratory pathogens among COVID-2019 cases.

Authors:  Xiaojuan Zhu; Yiyue Ge; Tao Wu; Kangchen Zhao; Yin Chen; Bin Wu; Fengcai Zhu; Baoli Zhu; Lunbiao Cui
Journal:  Virus Res       Date:  2020-05-11       Impact factor: 3.303

7.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

8.  COVID-19-Associated Histoplasmosis in an AIDS Patient.

Authors:  Rossana Patricia Basso; Vanice Rodrigues Poester; Jéssica Louise Benelli; David A Stevens; Heruza Einsfeld Zogbi; Izadora Clezar da S Vasconcellos; Alessandro Comarú Pasqualotto; Melissa Orzechowski Xavier
Journal:  Mycopathologia       Date:  2020-11-06       Impact factor: 2.574

9.  Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline.

Authors:  Elske Sieswerda; Mark G J de Boer; Marc M J Bonten; Wim G Boersma; René E Jonkers; Roel M Aleva; Bart-Jan Kullberg; Jeroen A Schouten; Ewoudt M W van de Garde; Theo J Verheij; Menno M van der Eerden; Jan M Prins; W Joost Wiersinga
Journal:  Clin Microbiol Infect       Date:  2020-10-01       Impact factor: 8.067

Review 10.  Characteristics of SARS-CoV-2 and COVID-19.

Authors:  Ben Hu; Hua Guo; Peng Zhou; Zheng-Li Shi
Journal:  Nat Rev Microbiol       Date:  2020-10-06       Impact factor: 78.297
View more
  11 in total

1.  Molecular Epidemiology of Hypervirulent K. pneumoniae and Problems of Health-Care Associated Infections.

Authors:  A V Tutelyan; D S Shlykova; Sh L Voskanyan; A M Gaponov; V M Pisarev
Journal:  Bull Exp Biol Med       Date:  2022-03-30       Impact factor: 0.737

2.  COVID-19 Clinical Profiles and Fatality Rates in Hospitalized Patients Reveal Case Aggravation and Selective Co-Infection by Limited Gram-Negative Bacteria.

Authors:  Kamaleldin B Said; Ahmed Alsolami; Safia Moussa; Fayez Alfouzan; Abdelhafiz I Bashir; Musleh Rashidi; Rana Aborans; Taha E Taha; Husam Almansour; Mashari Alazmi; Amal Al-Otaibi; Luluh Aljaloud; Basmah Al-Anazi; Ahmed Mohialdin; Ahmed Aljadani
Journal:  Int J Environ Res Public Health       Date:  2022-04-26       Impact factor: 4.614

Review 3.  The Complexity of Co-Infections in the Era of COVID-19.

Authors:  Nevio Cimolai
Journal:  SN Compr Clin Med       Date:  2021-04-23

Review 4.  Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis.

Authors:  M Nazmul Hoque; Salma Akter; Israt Dilruba Mishu; M Rafiul Islam; M Shaminur Rahman; Masuda Akhter; Israt Islam; Mehedi Mahmudul Hasan; Md Mizanur Rahaman; Munawar Sultana; Tofazzal Islam; M Anwar Hossain
Journal:  Microb Pathog       Date:  2021-05-04       Impact factor: 3.738

5.  Emergence of polymyxin B-heteroresistant hypervirulent Klebsiella pneumoniae from an individual in the community with asymptomatic bacteriuria.

Authors:  Jun Li; Mengli Tang; Fengjun Xia; Changhang Min; Yongmei Hu; Haichen Wang; Mingxiang Zou
Journal:  BMC Microbiol       Date:  2022-02-07       Impact factor: 3.605

6.  Increasing frequency of Aminoglycoside-Resistant Klebsiella pneumoniae during the era of pandemic COVID-19.

Authors:  Omar B Ahmed; Atif H Asghar; Fayez S Bahwerth
Journal:  Mater Today Proc       Date:  2021-05-21

7.  Carbapenem-Resistant Klebsiella pneumoniae Associated with COVID-19.

Authors:  Irina Magdalena Dumitru; Mirela Dumitrascu; Nicoleta Dorina Vlad; Roxana Carmen Cernat; Carmen Ilie-Serban; Aurelia Hangan; Raluca Elena Slujitoru; Aura Gherghina; Corina Mitroi-Maxim; Licdan Curtali; Dalia Sorina Carp; Anca Dumitrescu; Romelia Mitan; Rodica Lesanu; Sorin Rugina
Journal:  Antibiotics (Basel)       Date:  2021-05-11

8.  Genomic New Insights Into Emergence and Clinical Therapy of Multidrug-Resistant Klebsiella pneumoniae in Infected Pancreatic Necrosis.

Authors:  Haibin Hao; Yang Liu; Jin Cao; Kun Gao; Yingying Lu; Weiping Wang; Peng Wang; Sida Lu; Long Hu; Zhihui Tong; Weiqin Li
Journal:  Front Microbiol       Date:  2021-06-25       Impact factor: 5.640

9.  Isolation and Characterization of a Novel Lytic Bacteriophage against the K2 Capsule-Expressing Hypervirulent Klebsiella pneumoniae Strain 52145, and Identification of Its Functional Depolymerase.

Authors:  Botond Zsombor Pertics; Alysia Cox; Adrienn Nyúl; Nóra Szamek; Tamás Kovács; György Schneider
Journal:  Microorganisms       Date:  2021-03-21

10.  Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: an observational study from Italy, 2020-21.

Authors:  Marco Falcone; Giusy Tiseo; Gabriele Arcari; Alessandro Leonildi; Cesira Giordano; Sara Tempini; Giulia Bibbolino; Roberto Mozzo; Simona Barnini; Alessandra Carattoli; Francesco Menichetti
Journal:  J Antimicrob Chemother       Date:  2022-03-31       Impact factor: 5.758
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.